j. carl barrett
AstraZeneca (United States)
Wilmington, United States
Associate Editor
Cancer Genetics
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Associate Editors
dalia barsyte-lovejoy
University of Toronto
Toronto, Canada
Associate Editor
Cancer Molecular Targets and Therapeutics
riccardo bartoletti
University of Pisa
Pisa, Italy
Associate Editor
Genitourinary Oncology
hamid bassiri
Children's Hospital of Philadelphia
Philadelphia, United States
Associate Editor
Cancer Immunity and Immunotherapy
sreyashi basu
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Cancer Immunity and Immunotherapy
atrayee basu mallick
Thomas Jefferson University
Philadelphia, United States
Associate Editor
Cancer Metabolism
tone frost bathen
Norwegian University of Science and Technology
Trondheim, Norway
Associate Editor
Cancer Imaging and Image-directed Interventions
gerald batist
Segal Cancer Centre
Montreal, Canada
Associate Editor
Pharmacology of Anti-Cancer Drugs
janendra k batra
National Institute of Pathology (ICMR)
New Delhi, India
Associate Editor
Cancer Immunity and Immunotherapy
joshua michael bauml
Perelman School of Medicine, University of Pennsylvania
Philadelphia, United States
Associate Editor
Thoracic Oncology
dirk bausch
Ruhr University Bochum
Bochum, Germany
Associate Editor
Surgical Oncology
jose gilberto bazan
Ohio State University Hospital
Columbus, United States
Associate Editor
Thoracic Oncology
joal beane
The Ohio State University
Columbus, United States
Associate Editor
Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
andreas behren
Olivia Newton-John Cancer Research Institute
Heidelberg, Australia
Associate Editor
Cancer Immunity and Immunotherapy
sander bekeschus
Leibniz Institute for Plasma Research and Technology e.V. (INP)
Greifswald, Germany
Associate Editor
Skin Cancer
sander bekeschus
Leibniz Institute for Plasma Research and Technology e.V. (INP)
Greifswald, Germany
Associate Editor
Skin Cancer